Risk factors for pneumonitis in patients treated with anti‐programmed death‐1 therapy: A case‐control study

Immune checkpoint blockade‐related pneumonitis is a rare but potentially life‐threatening adverse effect, but its risk factors are not completely understood. This case‐control study was conducted to identify pneumonitis risk factors in patients treated with anti‐PD1 monoclonal antibodies (mAbs), inc...

Descripción completa

Detalles Bibliográficos
Autores principales: Cui, Pengfei, Liu, Zhefeng, Wang, Guoqiang, Ma, Junxun, Qian, Yuanyu, Zhang, Fan, Han, Chun, Long, Yaping, Li, Ye, Zheng, Xuan, Sun, Danyang, Zhang, Jing, Cai, Shangli, Jiao, Shunchang, Hu, Yi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2018
Materias:
Cancer Prevention
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6089164/
https://www.ncbi.nlm.nih.gov/pubmed/29797416
http://dx.doi.org/10.1002/cam4.1579

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6089164/
https://www.ncbi.nlm.nih.gov/pubmed/29797416
http://dx.doi.org/10.1002/cam4.1579

Ejemplares similares